Sunday, July 3, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study reveals psychological benefits of COVID-19 vaccination beyond reducing disease severity

by Medical Finance
in Coronavirus
New tool could help detect geographical hotspots for mental health problems caused by COVID
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

Getting vaccinated for COVID-19 measurably improved the psychological well-being of participants in the Understanding Coronavirus in America study, a large longitudinal look at the impact of the pandemic on individuals in the United States. Vaccination was associated with declines in distress and perceived risks of infection, hospitalization, and death. The study, appearing in the American Journal of Preventive Medicine, published by Elsevier, validates the intuitive but previously unanswered questions of whether becoming vaccinated reduces perceived risks associated with COVID-19, and whether the reduction of these fears leads to improvements in mental health and quality of life.

Our study documents important psychological benefits of vaccination beyond reducing the risk of severe illness and death associated with COVID-19.”


Jonathan Koltai, PhD, Lead Investigator, Department of Sociology, University of New Hampshire, Durham, NH, USA

Psychologic distress and anxiety increased sharply across the population following the onset of the COVID-19 pandemic. Several factors contributed, such as widespread job and income loss, food insecurity, social isolation, caregiving burdens, substance abuse, and racialized discrimination. Depressive symptoms persisted and increased into 2021 for those experiencing an accumulation of stress exposures. Not surprisingly, many individuals are also experiencing anticipatory fears that contribute to rising mental health problems.

Data from a nationally representative study of 8,090 adults who were interviewed regularly between March 2020 and June 2021 revealed declines in COVID-related risk perceptions and psychological distress following vaccination. Specifically, adults who received at least one dose of the COVID-19 vaccine between December 2020 and June 2021 reported a 7% relative reduction in mental distress, as measured using the Patient Health Questionnaire 4 (PHQ-4) distress scores, from average levels in the survey period immediately prior to vaccination.

Reductions in distress were partially explained by declining risk perceptions following vaccination. Becoming vaccinated was associated with a 7.77 percentage point decline in perceived risk of infection, a 6.91 percentage point decline in perceived risk of hospitalization, and a 4.68 percentage point decline in perceived risk of death. Adjusting for risk perceptions decreased the vaccination−distress association by 25%.

These effects persisted and became stronger up to at least eight weeks following vaccination. It is noteworthy that while responses from vaccinated and never-vaccinated participants followed similar trends pre-vaccination, they significantly diverged post-vaccination. Becoming vaccinated made people feel safer in addition to being safer.

The impact of vaccination on mental health varied by race/ethnicity. The largest reductions in distress were observed among American Indians (AI) and Alaska Native (AN) individuals, who have suffered disproportionately from COVID-19. The breakout among racial/ethnic groups was proportional to the overall US population during the study period, with the highest rates of vaccination observed among Asian and Pacific Islanders, and the lowest rates of vaccination observed among Black participants.

With the rapid rise of the Omicron variant in late 2021 and early 2022, urgent measures are needed to increase vaccination rates and achieve vaccine equity, both locally and globally. These efforts need to be coupled with effective communication about the benefits, both physical and mental, associated with vaccination.

Dr. Koltai stressed, “To ensure these benefits are widely shared, efforts to increase vaccination and booster rates in early 2022 need to prioritize equitable distribution and access to vaccines.”

Source:

Journal reference:

Koltai, J., et al. (2021) COVID-19 Vaccination and Mental Health: A Difference-In-difference Analysis of the Understanding America Study. American Journal of Preventive Medicine. doi.org/10.1016/j.amepre.2021.11.006.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Image Credit: FOTOGRIN/Shutterstock

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

by Medical Finance
July 3, 2022
0

A recent study published in The Lancet* assessed the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms and the...

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Colorado moves toward statewide coverage of wastewater surveillance

by Medical Finance
July 3, 2022
0

On a Sunday morning in March 2020, right at the start of the pandemic, an article in Popular Mechanics caught...

Study: Immunogenicity and Reactogenicity of BNT162b2 and mRNA1273 COVID-19 Vaccines Given as Fourth Dose Boosters in the COV-BOOST Randomised Trial Following Two Doses of ChAdOx1 nCov-19 or BNT162b2 and a Third Dose of BNT162b2. Image Credit: Tanya Dol/Shutterstock

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

by Medical Finance
July 3, 2022
0

In a recent study posted to Preprints with The Lancet*, researchers evaluated the immunogenicity of Pfizer’s BNT162b2 and Moderna’s messenger...

Study: Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA. Image Credit: ustas7777777 / Shutterstock.com

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

by Medical Finance
July 3, 2022
0

The ability of the immune system to prevent the replication and subsequent transmission of pathogens is referred to as ‘sterilizing...

Image Credit: Prostock-studio/Shutterstock

COVID-19 vaccination during pregnancy not associated with any observable birth defects on ultrasound

by Medical Finance
July 3, 2022
0

In our latest interview, News Medical speaks to Dr. Rachel Ruderman, a fourth-year resident at Northwestern University Feinberg School of...

Study: City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants. Image Credit: Aleksandar Malivuk / Shutterstock.com

Monitoring rise of SARS-CoV-2 variants in wastewater using genome sequencing

by Medical Finance
July 3, 2022
0

In a recent study published on the medRxiv* preprint server, researchers conduct genomic wastewater surveillance of the severe acute respiratory...

Next Post
Study: The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers. Image Credit: Marcos Homem / Shutterstock.com

Canadian study estimates incidence rate of reinfection in healthcare workers

Study: Predicting Epitope Candidates for SARS-CoV-2. Image Credit: creativeneko / Shutterstock.com

Prediction of SARS-CoV-2 epitope candidates for future vaccines

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation In Airway Epithelial Cells. Image Credit: Corona Borealis Studio / Shutterstock.com
    Researchers investigate Galectin-9 as a new treatment target for COVID-19
  • Intensive Care 620x480
    PerkinElmer expands genomic testing services with ultrarapid whole genome sequencing
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply